A multicenter, open, phase IV, 24-hour ambulatory blood pressure monitoring study of the efficacy and safety of Tarka [verapamil/trandolapril] in patients with arterial hypertension.

Trial Profile

A multicenter, open, phase IV, 24-hour ambulatory blood pressure monitoring study of the efficacy and safety of Tarka [verapamil/trandolapril] in patients with arterial hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Mar 2009

At a glance

  • Drugs Verapamil/trandolapril (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 09 Jul 2008 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
    • 09 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 09 Jul 2008 Actual patient number (120) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top